VCID: 273110
    Profile

    Corporate information

    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    Paradigm Diagnostics Inc
    United States 16 Feb 2017 Series B
    Active
    Exagen Diagnostics Inc
    United States 1 Sep 2012 N/A
    Active
    Elevation Pharmaceuticals Inc
    United States 1 Jan 2012
    1 Sep 2011
    Series B
    LineaGen Inc
    Novel biomarkers company for the development of new diagnostic tests.
    United States 1 Aug 2010
    1 Jan 2011
    Series B
    Active
    Traversa Therapeutics
    United States 1 Apr 2009 Series B
    Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.